Modulation of systemic hemodynamics by exogenous L-arginine in normal and bacteremic sheep

Crit Care Med. 1999 Nov;27(11):2474-9. doi: 10.1097/00003246-199911000-00025.

Abstract

Objective: To investigate whether exogenous L-arginine, the substrate for nitric oxide synthase, modulates systemic hemodynamics in sepsis.

Design: Prospective, controlled study in a sheep model of sepsis.

Setting: Animal research facility in a university hospital.

Subjects: Adult sheep weighing between 35 and 55 kg.

Interventions: Adult sheep sedated and mechanically ventilated, were monitored with a pulmonary arterial catheter and an ileal tonometer. Four groups of sheep were studied: nonseptic, septic, nonseptic treated with L-arginine, and septic treated with L-arginine. Sepsis was induced by the intravenous administration of Escherichia coli (1.5x10(8) colony-forming units/kg for 30 mins). L-arginine was administered as an intravenous bolus (200 mg/kg for 10 mins) before the septic challenge followed by 200 mg/kg/hr for 300 mins.

Measurements and main results: Sepsis induced a state of acidosis, hyperlactatemia, hypoxemia, and gastric intramucosal acidosis. During the first 30 mins after the septic challenge, there was a decrease in cardiac index and blood pressure, and an increase in systemic vascular resistance. Thereafter, blood pressure returned to baseline values, and systemic vascular resistance fell. Treatment with L-arginine in nonseptic sheep did not induce any biochemical or hemodynamic effect. In septic sheep, treatment with L-arginine was associated with a greater increase in systemic vascular resistance during the first 30 mins, and a more marked decrease in blood pressure and systemic vascular resistance after 180 mins.

Conclusions: Exogenous administration of L-arginine does not induce hemodynamic effects in normal animals, exacerbates the acute vasoconstriction associated with the intravenous infusion of E. coli and potentiates the sepsis-induced vasodilation. Our results suggest that a) nitric oxide production is not constitutively modulated by exogenous L-arginine, b) L-arginine probably enhances the sepsis-induced sympathetic discharge, and c) L-arginine becomes rate-limiting for the formation of nitric oxide at approximately 3 hrs after the initiation of the septic challenge.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acidosis / blood
  • Acidosis / drug therapy
  • Acidosis / etiology
  • Animals
  • Arginine / pharmacology*
  • Bacteremia / blood
  • Bacteremia / complications
  • Bacteremia / physiopathology*
  • Bacteremia / therapy
  • Blood Gas Analysis
  • Blood Pressure / drug effects*
  • Disease Models, Animal
  • Escherichia coli Infections / blood
  • Escherichia coli Infections / complications
  • Escherichia coli Infections / physiopathology
  • Escherichia coli Infections / therapy
  • Hydrogen-Ion Concentration
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology
  • Hypoxia / blood
  • Hypoxia / drug therapy
  • Hypoxia / etiology
  • Injections, Intravenous
  • Lactic Acid / blood
  • Leukopenia / blood
  • Leukopenia / drug therapy
  • Leukopenia / etiology
  • Prospective Studies
  • Pulmonary Wedge Pressure / drug effects
  • Respiration, Artificial
  • Sheep
  • Treatment Outcome
  • Vascular Resistance / drug effects*

Substances

  • Lactic Acid
  • Arginine